RU2116308C1 - Триазолпиримидиновые производные и фармацевтическая композиция - Google Patents

Триазолпиримидиновые производные и фармацевтическая композиция Download PDF

Info

Publication number
RU2116308C1
RU2116308C1 RU94040854A RU94040854A RU2116308C1 RU 2116308 C1 RU2116308 C1 RU 2116308C1 RU 94040854 A RU94040854 A RU 94040854A RU 94040854 A RU94040854 A RU 94040854A RU 2116308 C1 RU2116308 C1 RU 2116308C1
Authority
RU
Russia
Prior art keywords
formula
propyl
methyl
group
pyrimidine
Prior art date
Application number
RU94040854A
Other languages
English (en)
Russian (ru)
Other versions
RU94040854A (ru
Inventor
Николь-Брю-Маньез
Гюнгор Тимур
Телон Жан-Мари
Original Assignee
Лаборатуар Юпса
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9202109A external-priority patent/FR2687676B1/fr
Application filed by Лаборатуар Юпса filed Critical Лаборатуар Юпса
Publication of RU94040854A publication Critical patent/RU94040854A/ru
Application granted granted Critical
Publication of RU2116308C1 publication Critical patent/RU2116308C1/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
RU94040854A 1992-02-24 1993-02-18 Триазолпиримидиновые производные и фармацевтическая композиция RU2116308C1 (ru)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
FR9202109A FR2687676B1 (fr) 1992-02-24 1992-02-24 Nouveaux derives de polyazaindenes antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.
FR92-02109 1992-02-24
FR9202109 1992-02-24
FR92-05417 1992-04-30
FR9205417A FR2687677B1 (fr) 1992-02-24 1992-04-30 Nouveaux derives de polyazaindenes antagonistes des recepteurs a l'angiotensine ii ; leurs procedes de preparation, compositions pharmaceutiques les contenant.
FR9205417 1992-04-30

Publications (2)

Publication Number Publication Date
RU94040854A RU94040854A (ru) 1996-08-10
RU2116308C1 true RU2116308C1 (ru) 1998-07-27

Family

ID=26229283

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94040854A RU2116308C1 (ru) 1992-02-24 1993-02-18 Триазолпиримидиновые производные и фармацевтическая композиция

Country Status (19)

Country Link
EP (2) EP0628046B1 (et)
JP (2) JPH07504177A (et)
KR (2) KR100272922B1 (et)
AT (1) ATE179979T1 (et)
AU (2) AU668544B2 (et)
CA (2) CA2128871A1 (et)
CZ (2) CZ282075B6 (et)
DE (1) DE69324910T2 (et)
EE (2) EE03045B1 (et)
ES (1) ES2133390T3 (et)
FI (2) FI943808A (et)
FR (1) FR2687677B1 (et)
HU (2) HU220392B (et)
MD (2) MD553G2 (et)
NZ (2) NZ249508A (et)
RU (1) RU2116308C1 (et)
SK (2) SK99894A3 (et)
TW (2) TW222275B (et)
WO (2) WO1993017023A1 (et)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5389632A (en) * 1992-02-24 1995-02-14 Laboratoires Upsa Pyrazolopyrimidine derivatives which are angiotensin II receptor antagonists
IT1263804B (it) * 1993-01-22 1996-09-03 Luso Farmaco Inst Derivati pirimidinonici fusi con eterocicli azotati ad attivita' a ii antagonista
US5571813A (en) * 1993-06-10 1996-11-05 Beiersdorf-Lilly Gmbh Fused pyrimidine compounds and their use as pharmaceuticals
WO2006114405A2 (de) * 2005-04-25 2006-11-02 Basf Aktiengesellschaft Verwendung von 5-alkyl-6-phenylalkyl-7-amino-azolopyrimidinen, neue azolopyrimidine, verfahren zu ihrer herstellung und sie enthaltende mittel
WO2008003753A1 (en) * 2006-07-07 2008-01-10 Biovitrum Ab (Publ) Pyrazolo [1,5-a] pyrimidine analogs for use as inhibitors of stearoyl-coa desaturase (scd) activity
DE102006039255A1 (de) * 2006-08-17 2008-02-21 Bayer Cropscience Ag Insektizide heterocyclische Carbonsäurederivate
MX2011008058A (es) * 2009-01-30 2011-09-01 Takeda Pharmaceutical Compuesto de anillo fusionado y su uso.
SG189086A1 (en) 2010-09-27 2013-05-31 Proximagen Ltd 7-hydroxy-pyrazolo[1,5-a] pyrimidine compounds and their use as ccr2 receptor antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
EP0522038A4 (en) * 1990-03-30 1993-05-26 Merck & Co. Inc. Substituted pyrimidines, pyrimidinones and pyridopyrimidines
FR2678618B1 (fr) * 1991-07-05 1993-11-05 Upsa Laboratoires Nouveaux derives de triazolo pyrimidine antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
SK99794A3 (en) 1995-04-12
EP0628045A1 (fr) 1994-12-14
TW221438B (et) 1994-03-01
JPH07504177A (ja) 1995-05-11
MD554F1 (en) 1996-05-31
FI943808A0 (fi) 1994-08-19
FI943807A (fi) 1994-10-24
HU9402430D0 (en) 1994-10-28
CA2128876A1 (en) 1993-09-02
FI943807A0 (fi) 1994-08-19
CA2128871A1 (en) 1993-09-02
KR950700303A (ko) 1995-01-16
AU668544B2 (en) 1996-05-09
KR950700302A (ko) 1995-01-16
AU3635793A (en) 1993-09-13
JP3372040B2 (ja) 2003-01-27
WO1993017024A1 (fr) 1993-09-02
WO1993017023A1 (fr) 1993-09-02
ATE179979T1 (de) 1999-05-15
KR100272922B1 (ko) 2001-02-01
DE69324910D1 (de) 1999-06-17
AU668139B2 (en) 1996-04-26
NZ249509A (en) 1996-06-25
HU220392B (hu) 2002-01-28
HU9402429D0 (en) 1994-10-28
EE03046B1 (et) 1997-10-15
CZ282075B6 (cs) 1997-05-14
MD553F1 (en) 1996-05-31
NZ249508A (en) 1996-07-26
HUT70953A (en) 1995-11-28
EE03045B1 (et) 1997-10-15
FI943808A (fi) 1994-10-24
HUT70949A (en) 1995-11-28
CA2128876C (en) 2004-02-03
ES2133390T3 (es) 1999-09-16
RU94040854A (ru) 1996-08-10
EP0628046B1 (fr) 1999-05-12
CZ204494A3 (en) 1994-12-15
TW222275B (et) 1994-04-11
SK99894A3 (en) 1995-04-12
AU3635893A (en) 1993-09-13
MD553G2 (ro) 1996-12-31
FR2687677B1 (fr) 1996-10-11
FR2687677A1 (fr) 1993-08-27
JPH07504178A (ja) 1995-05-11
MD554G2 (ro) 1997-01-31
CZ204594A3 (en) 1994-12-15
EP0628046A1 (fr) 1994-12-14
DE69324910T2 (de) 1999-10-21
SK280343B6 (sk) 1999-12-10

Similar Documents

Publication Publication Date Title
US5977118A (en) 6-substituted pyrazolo[3,4-d]pyrimidin-4-ones and compositions and methods of use thereof
US4879296A (en) Xanthine derivatives
CZ376799A3 (cs) Pyrazolopyrimidinony, které inhibují typ 5 cyklické guanosin 3',5'-monofosfatfosfodiesterasy (cGMP /DE5) pro léčení sexuální dysfunkce
JP3140566B2 (ja) アンギオテンシンｉｉリセプタ拮抗剤である新規なトリアゾロピリミジン誘導体、その製造方法、およびそれを含有する医薬組成物
US5231094A (en) Triazolopyrimidines which are angiotensin II receptor antagonists and pharmaceutical compositions in which they are present
GB2244487A (en) Azple derivatives
JP3116230B2 (ja) 三環式縮合ピリミジン誘導体
RU2116308C1 (ru) Триазолпиримидиновые производные и фармацевтическая композиция
US5387747A (en) Triazolopyrimidine derivatives which are angiotensin II receptor antagonists, their methods of preparation and pharmaceutical compositions in which they are present
DE69029303T2 (de) 5-Triazolo(3,4-i)purinderivate
US5389632A (en) Pyrazolopyrimidine derivatives which are angiotensin II receptor antagonists